Literature DB >> 18803018

Safety in human research: past problems and current challenges from a Canadian perspective.

Barry Schwartz1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18803018     DOI: 10.1007/s10730-008-9076-3

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


× No keyword cloud information.
  19 in total

1.  Good science or good business?

Authors:  D Healy
Journal:  Hastings Cent Rep       Date:  2000 Mar-Apr       Impact factor: 2.683

2.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Ethics review for sale? Conflict of interest and commercial research review boards.

Authors:  T Lemmens; B Freedman
Journal:  Milbank Q       Date:  2000       Impact factor: 4.911

4.  Subject indifference and the justification of placebo-controlled trials.

Authors:  Robert M Veatch
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

5.  The social and cultural shaping of medical evidence: case studies from pharmaceutical research and obstetric science.

Authors:  Raymond De Vries; Trudo Lemmens
Journal:  Soc Sci Med       Date:  2005-12-22       Impact factor: 4.634

Review 6.  Conflict of interest and institutional review boards.

Authors:  M K Cho; P Billings
Journal:  J Investig Med       Date:  1997-04       Impact factor: 2.895

7.  The Willowbrook hepatitis studies revisited: ethical aspects.

Authors:  S Krugman
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

8.  Clarifying the concepts of research ethics.

Authors:  R J Levine
Journal:  Hastings Cent Rep       Date:  1979-06       Impact factor: 2.683

9.  African Americans' views on research and the Tuskegee Syphilis Study.

Authors:  V S Freimuth; S C Quinn; S B Thomas; G Cole; E Zook; T Duncan
Journal:  Soc Sci Med       Date:  2001-03       Impact factor: 4.634

10.  Bioethics, vulnerability, and protection.

Authors:  Ruth Macklin
Journal:  Bioethics       Date:  2003-10       Impact factor: 1.898

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.